Bronchiectasis: Clinical Trials

2 trials for Bronchiectasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Active not recruiting 2

Follow Bronchiectasis: new trials by email Literature Review of Bronchiectasis trials Research Report on Bronchiectasis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Multicenter, Randomized, Double-blind, Placebo-controlled Parallel-group Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of XH-S004 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis
XH-S004 20 mg, XH-S004 40 mg, Placebo - Non-Cystic Fibrosis Bronchiectasis
Phase 2Active not recruitingShanghai Fosun Pharmaceutical Industrial Development Co. Ltd.2342025-05-302026-09-25
Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine
BI 1291583, Placebo matching BI 1291583 - Bronchiectasis
Phase 2Active not recruitingBoehringer Ingelheim2682023-09-082026-10-14

Narrower conditions

Fibrosis (1)

Broader conditions

Bronchial Diseases (2)  ·  Respiratory Tract Diseases (2)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Sponsors

Boehringer Ingelheim (1)  ·  Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. (1)

Countries

Australia (1)  ·  Belgium (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  China (1)  ·  Czechia (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Israel (1)  ·  Italy (1)  ·  Japan (1)  ·  Latvia (1)  ·  Mexico (1)

Results publications

PMID 39175217

NIH funding

2023 (1)